Of the known melanoma driver mutations (BRAF, NRAS and NF1), only BRAF was mutated significantly more frequently in the better than in the poorer prognostic group (162/301 vs. 16/55; Fisher’s exact test, P = 0.001). This evidence concerns the gene NF1 and melanoma.